An exploratory, open-label, randomized, multicenter study to investigate the pharmacodynamics of a glycoengineered antibody (imgatuzumab) and cetuximab in patients with operable head and neck squamous cell carcinoma

S Temam, J Spicer, F Farzaneh, J C Soria, D Oppenheim, M McGurk, A Hollebecque, J Sarini, K Hussain, S Soehrman Brossard, L Manenti, S Evers, P Delmar, L Di Scala, C Mancao, F Feuerhake, L Andries, M G Ott, A Passioukov, J P Delord

Research output: Contribution to journal › Article › peer-review

19 Citations (Scopus)

Fingerprint

Dive into the research topics of 'An exploratory, open-label, randomized, multicenter study to investigate the pharmacodynamics of a glycoengineered antibody (imgatuzumab) and cetuximab in patients with operable head and neck squamous cell carcinoma'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology